Pascal Jean-Pierre1,2, Ying Cheng1, Kristen J Wells3, Karen M Freund4, Frederick R Snyder5, Kevin Fiscella6, Alan E Holden7, Electra D Paskett8, Donald J Dudley9, Melissa A Simon10, Patricia A Valverde11. 1. Department of Psychology, University of Notre Dame, South Bend, Indiana. 2. Cancer Neurocognitive Translational Research Laboratory, University of Notre Dame, South Bend, Indiana. 3. Department of Psychology, San Diego State University, San Diego, California. 4. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts. 5. NOVA Research Company, Silver Spring, Maryland. 6. Department of Family Medicine and Public Health Sciences, University of Rochester Medical Center, Rochester, New York. 7. Institute for Health Promotion Research, University of Texas Health Science Center, San Antonio, Texas. 8. Comprehensive Cancer Center, Ohio State University, Columbus, Ohio. 9. Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, Virginia. 10. Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 11. Colorado School of Public Health, University of Colorado at Denver, Denver, Colorado.
Abstract
BACKGROUND: Patient navigation is a barrier-focused program of care coordination designed to achieve timely and high-quality cancer-related care for medically underserved racial-ethnic minorities and the poor. However, to the authors' knowledge, few studies to date have examined the relationship between satisfaction with navigators and cancer-related care. METHODS: The authors included data from 1345 patients with abnormal cancer screening tests or a definitive cancer diagnosis who participated in the Patient Navigation Research Program to test the efficacy of patient navigation. Participants completed demographic questionnaires and measures of patient satisfaction with cancer-related care (PSCC) and patient satisfaction with interpersonal relationship with navigator (PSN-I). The authors obtained descriptive statistics to characterize the sample and conducted regression analyses to assess the degree of association between PSN-I and PSCC, controlling for demographic and clinical factors. Analyses of variance were conducted to examine group differences controlling for statistically significant covariates. RESULTS: Statistically significant relationships were found between the PSCC and PSN-I for patients with abnormal cancer screening tests (1040 patients; correlation coefficient (r), 0.4 [P<.001]) and those with a definitive cancer diagnosis (305 patients; correlation coefficient, 0.4 [P<.001]). The regression analysis indicated that having an abnormal colorectal cancer screening test in the abnormal screening test group and increased age and minority race-ethnicity status in the cancer diagnosis group were associated with a higher satisfaction with cancer care (P<.01). CONCLUSIONS: Satisfaction with navigators appears to be significantly associated with satisfaction with cancer-related care. Information regarding the patient-navigator relationship should be integrated into patient navigation programs to maximize the likelihood of reducing caner disparities and mortality for medically underserved racial-ethnic minorities and the poor.
BACKGROUND:Patient navigation is a barrier-focused program of care coordination designed to achieve timely and high-quality cancer-related care for medically underserved racial-ethnic minorities and the poor. However, to the authors' knowledge, few studies to date have examined the relationship between satisfaction with navigators and cancer-related care. METHODS: The authors included data from 1345 patients with abnormal cancer screening tests or a definitive cancer diagnosis who participated in the Patient Navigation Research Program to test the efficacy of patient navigation. Participants completed demographic questionnaires and measures of patient satisfaction with cancer-related care (PSCC) and patient satisfaction with interpersonal relationship with navigator (PSN-I). The authors obtained descriptive statistics to characterize the sample and conducted regression analyses to assess the degree of association between PSN-I and PSCC, controlling for demographic and clinical factors. Analyses of variance were conducted to examine group differences controlling for statistically significant covariates. RESULTS: Statistically significant relationships were found between the PSCC and PSN-I for patients with abnormal cancer screening tests (1040 patients; correlation coefficient (r), 0.4 [P<.001]) and those with a definitive cancer diagnosis (305 patients; correlation coefficient, 0.4 [P<.001]). The regression analysis indicated that having an abnormal colorectal cancer screening test in the abnormal screening test group and increased age and minority race-ethnicity status in the cancer diagnosis group were associated with a higher satisfaction with cancer care (P<.01). CONCLUSIONS: Satisfaction with navigators appears to be significantly associated with satisfaction with cancer-related care. Information regarding the patient-navigator relationship should be integrated into patient navigation programs to maximize the likelihood of reducing caner disparities and mortality for medically underserved racial-ethnic minorities and the poor.
Authors: Karen M Freund; Tracy A Battaglia; Elizabeth Calhoun; Donald J Dudley; Kevin Fiscella; Electra Paskett; Peter C Raich; Richard G Roetzheim Journal: Cancer Date: 2008-12-15 Impact factor: 6.860
Authors: Kristen J Wells; Tracy A Battaglia; Donald J Dudley; Roland Garcia; Amanda Greene; Elizabeth Calhoun; Jeanne S Mandelblatt; Electra D Paskett; Peter C Raich Journal: Cancer Date: 2008-10-15 Impact factor: 6.860
Authors: Elizabeth A Calhoun; Elizabeth M Whitley; Angelina Esparza; Elizabeth Ness; Amanda Greene; Roland Garcia; Patricia A Valverde Journal: Health Promot Pract Date: 2008-12-30
Authors: Alix G Sleight; Kathleen Doyle Lyons; Cheryl Vigen; Heather Macdonald; Florence Clark Journal: Support Care Cancer Date: 2018-05-16 Impact factor: 3.603
Authors: Diego Lopez; Mandi L Pratt-Chapman; Elizabeth A Rohan; Lisa Kennedy Sheldon; Karen Basen-Engquist; Ron Kline; Lawrence N Shulman; Efren J Flores Journal: Support Care Cancer Date: 2019-03-18 Impact factor: 3.603
Authors: Lynn M Yee; Brittney Williams; Hannah M Green; Viridiana Carmona-Barrera; Laura Diaz; Ka'Derricka Davis; Michelle A Kominiarek; Joe Feinglass; Chloe A Zera; William A Grobman Journal: Am J Obstet Gynecol Date: 2021-04-01 Impact factor: 10.693